Lista de obras - Nicola Valeri - Dominio Público Uruguay

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protoc ⬇️

artículo científico publicado en 2017

An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

artículo científico publicado en 2014

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases

scientific article published on 06 September 2018

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

artículo científico publicado en 2011

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

scientific article published on 03 August 2018

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

artículo científico publicado en 2017

Characterisation of the immune-related transcriptome in resected biliary tract cancers

artículo científico publicado en 2017

Combining Molecularly Targeted Agents: Is More Always Better?

artículo científico publicado en 2016

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

artículo científico publicado en 2020

Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.

artículo científico publicado en 2017

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial ⬇️

artículo científico publicado en 2016

Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience

scientific article published on 29 September 2018

Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma ⬇️

artículo científico publicado el 27 de diciembre de 2010

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker anal

artículo científico publicado en 2017

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

artículo científico

HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer

article

Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes

artículo científico publicado en 2010

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

scientific article published on 27 March 2008

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

artículo científico publicado en 2018

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study

scientific article published on 10 January 2008

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

artículo científico publicado en 2018

LONG-NONCODING RNAs in gastroesophageal cancers

artículo científico publicado en 2018

Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis

artículo científico publicado en 2015

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

artículo científico publicado en 2018

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma

artículo científico publicado en 2017

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer

artículo científico publicado en 2021

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.

artículo científico publicado en 2016

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer

artículo científico publicado en 2014

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) ⬇️

artículo científico publicado el 15 de noviembre de 2010

MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours

artículo científico publicado en 2018

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches

scholarly article by Margherita Ratti published in September 2018

Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.

artículo científico publicado en 2017

Modulation of mismatch repair and genomic stability by miR-155

artículo científico publicado en 2010

New target therapies in advanced pancreatic cancer.

artículo científico publicado en 2006

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.

artículo científico publicado en 2018

Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells

artículo científico publicado en 2011

Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications

artículo científico publicado en 2018

Pathogenetic and clinical relevance of microRNAs in colorectal cancer.

artículo científico publicado en 2009

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

artículo científico publicado en 2018

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy

artículo científico publicado en 2017

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.

artículo científico publicado en 2015

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial. ⬇️

artículo científico publicado en 2018

Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples

artículo científico publicado en 2012

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

scientific article published on 05 July 2016

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer

article

The molecular landscape of colitis-associated carcinogenesis.

artículo científico publicado en 2016

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis ⬇️

artículo científico publicado en 2014

Translational research and application of basic biology to clinical trial development in GI cancers.

artículo científico publicado en 2018

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers

artículo científico publicado en 2016

c-Src drives intestinal regeneration and transformation

artículo científico publicado en 2014

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

artículo científico publicado en 2018

rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer

artículo científico publicado en 2012

Lista de obras de Nicola Valeri

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protoc ⬇️

An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

Characterisation of the immune-related transcriptome in resected biliary tract cancers

Combining Molecularly Targeted Agents: Is More Always Better?

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial ⬇️

Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience

Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma ⬇️

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker anal

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer

Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

LONG-NONCODING RNAs in gastroesophageal cancers

Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) ⬇️

MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches

Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.

Modulation of mismatch repair and genomic stability by miR-155

New target therapies in advanced pancreatic cancer.

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.

Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells

Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications

Pathogenetic and clinical relevance of microRNAs in colorectal cancer.

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial. ⬇️

Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer

The molecular landscape of colitis-associated carcinogenesis.

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis ⬇️

Translational research and application of basic biology to clinical trial development in GI cancers.

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers

c-Src drives intestinal regeneration and transformation

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer